In this study, to identify novel responsible loci for the response to tamoxifen therapy, we carried out a genome-wide association study (GWAS) and identified novel three loci associated with Ki-67 change after short-term tamoxifen therapy in the breast cancer patients treated with tamoxifen. This evidence concerns the gene MKI67 and breast cancer.